Biohaven Ltd. DEF 14A: Executive Compensation Details
Ticker: BHVN · Form: DEF 14A · Filed: Mar 18, 2025 · CIK: 1935979
| Field | Detail |
|---|---|
| Company | Biohaven Ltd. (BHVN) |
| Form Type | DEF 14A |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, corporate-governance, sec-filing
TL;DR
Biohaven's 2025 DEF 14A is out, detailing exec pay & equity awards for 2022-2024. Focus on NEOs & Non-NEOs.
AI Summary
Biohaven Ltd. filed its DEF 14A on March 18, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key information includes compensation details for Named Executive Officers (NEOs) and Non-NEO members for the fiscal years 2022, 2023, and 2024, with a focus on equity awards.
Why It Matters
This filing provides transparency into how Biohaven Ltd. compensates its top executives, which can influence investor decisions and perceptions of the company's management and financial health.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and corporate governance, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 2024 — Fiscal Year (Executive compensation data covers this year.)
- 2023 — Fiscal Year (Executive compensation data covers this year.)
- 2022 — Fiscal Year (Executive compensation data covers this year.)
Key Players & Entities
- Biohaven Ltd. (company) — Filer of the DEF 14A
- 0001935979-25-000022 (dollar_amount) — Accession Number for the filing
- 20250318 (dollar_amount) — Filing date
- 20250505 (dollar_amount) — Conformed period of report
- 2024-12-31 (dollar_amount) — Fiscal year end
FAQ
What is the primary purpose of this DEF 14A filing for Biohaven Ltd.?
The primary purpose is to provide detailed information regarding executive compensation, director compensation, and other corporate governance matters for the fiscal year ending December 31, 2024.
What period does the executive compensation data in this filing cover?
The filing provides data for the fiscal years 2024, 2023, and 2022.
What specific types of compensation are detailed for executives?
The filing details equity awards granted and vested for both 'PeoMember' (Principal Executive Officer) and 'NonPeoNeoMember' (Non-Principal Executive Officer) categories.
When was this DEF 14A filing submitted to the SEC?
The filing was submitted on March 18, 2025.
What is Biohaven Ltd.'s Standard Industrial Classification (SIC) code?
Biohaven Ltd.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 18, 2025 regarding Biohaven Ltd. (BHVN).